Page 137 - JSOM Summer 2020
P. 137
Importantly, there is evidence that some ingredients present 5. Wilms W, Wozniak-Karczewska M, et al. Nootropic drugs: meth-
or hidden from the labels of products currently on the mar- ylphenidate, modafinil and piracetam—population use trends,
ket do not meet the regulatory framework for being a dietary occurrence in the environment, ecotoxicity and removal methods:
supplement ingredient, some considered as unapproved drugs. a review. Chemosphere. 2019;233:771–785.
Just because a product is on the market does not mean it has 6. Binns CW, Lee MK, Lee AH. Problems and prospects: pub-
lic health regulation of dietary supplements. Annu Rev Public
been shown to be safe. Becoming familiar with red flag and Health. 2018;39:403–420.
prohibited ingredients, avoiding high-risk products, and using 7. FDA. New dietary ingredients in dietary supplements—back-
educational tools such as OPSS scorecard are important. To- ground for industry. https://www.fda.gov/food/new-dietary
gether, these resources can help users make informed decisions -ingredients-ndi-notification-process/new-dietary-ingredients
in real-time about dietary supplements and reduce the poten- -dietary-supplements-background-industry. 2019. Accessed on
March 30, 2020.
tial risks to their health and careers. 8. Deuster PA. What the SOF community needs to know about di-
etary supplements. J Spec Oper Med. 2018;18(4):131–136.
Acknowledgments 9. Crawford C, Boyd C, Avula B, et al. A public health issue: di-
The authors would like to acknowledge Ms Andrea T. Lind- etary supplements promoted for brain health and cognitive per-
sey, Director of Operation Supplement Safety (OPSS.org), for formance. J Altern Complement Med. 2020. Mar 2. doi:10.1089/
her contributions, as well as the National Center for Natural acm.2019.0447
Products Research, University of Mississippi, MS, for their 10. Crawford C, Wang YH, Avula B, et al. The scoop on brain health
analysis of products. dietary supplement products containing huperzine A. Clin Toxi-
col (Philadelphia, Pa). 2020:1–6.
11. D’Cunha NM, Georgousopoulou EN, Dadigamuwage L, et al.
Authorship Contributions Effect of long-term nutraceutical and dietary supplement use
CC and PD were responsible for the concept, design, analysis, on cognition in the elderly: a 10-year systematic review of ran-
and interpretation of the data. CC wrote the first draft and domised controlled trials. Br J Nutr. 2018;119(3):280–298.
PD revised it critically; both authors approve the final version. 12. Operation Supplement Safety. Screen your supplement for
safety. https://www.opss.org/screen-your-supplement-safety-read
Funding -label-your-supplement-and-answer-these-questions. Accessed on
Funding for this work was provided by the Preservation of the March 30, 2020.
Force and Family Behavioral Health Program, Uniformed Ser- 13. Operation Supplement Safety. Dietary supplement ingredients
vices University award number HU0001-15-2-0053 and Oper- prohibited by the Department of Defense. https://www.opss.org
/dietary-supplement-ingredients-prohibited-department-defense.
ation Supplement Safety award number HU0001-18-2-0099. Accessed on March 30, 2020.
14. FDA. Statement on warning for women of childbearing age about
Disclosures possible safety risks of dietary supplements containing vinpocetine.
The opinions and assertions expressed herein are those of https://www.fda.gov/news-events/press-announcements/statement
the author(s) and do not necessarily reflect the official policy -warning-women-childbearing-age-about-possible-safety
or position of the Uniformed Services University, US Special -risks-dietary-supplements-containing. 2019; Accessed on March
30, 2020.
Operations Command, or the Department of Defense. The 15. FDA. Dietary supplement ingredient advisory list. https://www.fda
contents of this publication are the sole responsibility of the .gov/food/dietary-supplement-products-ingredients/dietary
author(s) and do not necessarily reflect the views, opinions -supplement-ingredient-advisory-list. 2020; Accessed on March
or policies of The Henry M. Jackson Foundation for the Ad- 30, 2020.
vancement of Military Medicine. 16. Hornykiewicz O. How L-DOPA was discovered as a drug for
Parkinson’s disease 40 years ago. Wiener klinische Wochen-
Conflict of Interest schrift. 2001;113(22):855-862.
The authors have no financial interests or relationships to 17. Mukherjee E, Gantait S, Kundu S, et al. Biotechnological interven-
disclose. tions on the genus Rauvolfia: recent trends and imminent pros-
pects. Appl Microbiol and Biotechnol. 2019;103(18):7325-7354.
18. Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities
References of yohimbine found in dietary supplements in the USA. Drug Test
1. Operation Supplement Safety. Ask the Expert. https://www.opss Anal. 2016;8(3–4):357–369.
.org/ask-the-expert. Accessed on March 30, 2020. 19. Dean BV, Stellpflug SJ, Burnett AM, Engebretsen KM. 2C or not
2. Global Counsel on Brain Health. The Real Deal on Brain Health 2C: phenethylamine designer drug review. J Med Toxicol. 2013;9
Supplements: Global Counsel on Brain Health Recommendations (2):172–178.
on Vitamins, Minerals, and Other Dietary Supplements. Available at 20. King LA. New phenethylamines in Europe. Drug Test Anal.
www.GlobalCouncilOnBrainHealth.org DOI: https://www.aarp.org 2014;6(7–8):808–818.
/content/dam/aarp/health/brain_health/2019/06/gcbh-supplements 21. FDA. Vinpocetine in dietary supplements. https://www.fda.gov
-report-english.doi.10.26419-2Fpia.00094.001.pdf. /food/dietary-supplement-products-ingredients/vinpocetine
3. United States Congress. Dietary supplement health and education -dietary-supplements. 2019; Accessed on March 30, 2020.
act of 1994. PubL103-417. 1994; www.congress.gov. Accessed on
March 30, 2020.
4. Cui CC, Sun Y, Wang XY, et al. The effect of anti-dementia drugs on
Alzheimer disease-induced cognitive impairment: a network meta-
analysis. Medicine. 2019;98(27):e16091. doi:10.1097/md.000000
0000016091
Dietary Supplements for Cognitive Performance | 135

